Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Vascular Ehlers-Danlos Syndrome Diagnosis and Management

Diagnostic Testing

  • The American Heart Association recommends COL3A1 gene mutation testing as the definitive diagnostic test for vascular Ehlers-Danlos syndrome (vEDS), which should be performed urgently when this life-threatening condition is suspected 1, 2
  • Characteristic facial features, such as thin nose, thin upper lip, small earlobes, and prominent eyes, are associated with vEDS 1
  • Thin, translucent skin with visible veins is a common feature of vEDS 1
  • Easy bruising without significant trauma is a symptom of vEDS 1

Diagnostic Testing Algorithm

  • The American College of Cardiology recommends ordering COL3A1 gene mutation testing immediately when vEDS is suspected, as it is the gold standard for diagnosis 1, 2
  • A multi-gene panel covering COL3A1, COL5A1, COL5A2, TGFBR1, TGFBR2, PLOD1, and other arteriopathy genes can be ordered if the clinical picture is unclear regarding EDS subtype 2

Critical Pre-Testing Laboratory Work

  • Baseline serum tryptase level should be obtained to distinguish from myeloproliferative variants with arteriopathy 2
  • Vitamin B12 level should be checked, as it is characteristically elevated in myeloproliferative variants 2
  • Complete blood count with differential should be performed to evaluate for cytopenias or eosinophilia 2
  • Comprehensive metabolic panel, including liver and renal function, should be obtained 2

Essential Imaging Studies

  • MR angiography from head to pelvis should be performed to assess for arterial tortuosity, aneurysms, and dissections throughout the entire vascular tree 1, 2
  • Annual surveillance imaging is required once diagnosis is confirmed 1

Genetic Counseling Requirements

  • Formal genetic counseling should be referred before mutation screening due to complex financial, insurance, familial, and social implications 2
  • Lifelong surveillance strategies, including annual imaging from cerebrovascular circulation to pelvis, should be implemented 1
  • Family screening is necessary due to autosomal dominant inheritance with 50% transmission risk 2
  • Pregnancy planning should be carefully considered due to high maternal mortality risk from uterine and arterial rupture 1
  • Surgical risk stratification is crucial due to tissue fragility complicating all procedures 1